BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

203 related articles for article (PubMed ID: 22088954)

  • 1. Roscovitine inhibits CaV3.1 (T-type) channels by preferentially affecting closed-state inactivation.
    Yarotskyy V; Elmslie KS
    J Pharmacol Exp Ther; 2012 Feb; 340(2):463-72. PubMed ID: 22088954
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Roscovitine, a cyclin-dependent kinase inhibitor, affects several gating mechanisms to inhibit cardiac L-type (Ca(V)1.2) calcium channels.
    Yarotskyy V; Elmslie KS
    Br J Pharmacol; 2007 Oct; 152(3):386-95. PubMed ID: 17700718
    [TBL] [Abstract][Full Text] [Related]  

  • 3. State-dependent block of HERG potassium channels by R-roscovitine: implications for cancer therapy.
    Ganapathi SB; Kester M; Elmslie KS
    Am J Physiol Cell Physiol; 2009 Apr; 296(4):C701-10. PubMed ID: 19244476
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Domain III regulates N-type (CaV2.2) calcium channel closing kinetics.
    Yarotskyy V; Gao G; Peterson BZ; Elmslie KS
    J Neurophysiol; 2012 Apr; 107(7):1942-51. PubMed ID: 22205645
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Niflumic acid blocks native and recombinant T-type channels.
    Balderas E; Ateaga-Tlecuitl R; Rivera M; Gomora JC; Darszon A
    J Cell Physiol; 2012 Jun; 227(6):2542-55. PubMed ID: 21898399
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Roscovitine differentially affects CaV2 and Kv channels by binding to the open state.
    Buraei Z; Schofield G; Elmslie KS
    Neuropharmacology; 2007 Mar; 52(3):883-94. PubMed ID: 17125805
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Slowed N-type calcium channel (CaV2.2) deactivation by the cyclin-dependent kinase inhibitor roscovitine.
    Buraei Z; Anghelescu M; Elmslie KS
    Biophys J; 2005 Sep; 89(3):1681-91. PubMed ID: 15951378
    [TBL] [Abstract][Full Text] [Related]  

  • 8. (R)-roscovitine prolongs the mean open time of unitary N-type calcium channel currents.
    DeStefino NR; Pilato AA; Dittrich M; Cherry SV; Cho S; Stiles JR; Meriney SD
    Neuroscience; 2010 May; 167(3):838-49. PubMed ID: 20188151
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Zn(2+) slows down Ca(V)3.3 gating kinetics: implications for thalamocortical activity.
    Cataldi M; Lariccia V; Marzaioli V; Cavaccini A; Curia G; Viggiano D; Canzoniero LM; di Renzo G; Avoli M; Annunziato L
    J Neurophysiol; 2007 Oct; 98(4):2274-84. PubMed ID: 17699699
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Inhibition of recombinant Ca(v)3.1 (alpha(1G)) T-type calcium channels by the antipsychotic drug clozapine.
    Choi KH; Rhim H
    Eur J Pharmacol; 2010 Jan; 626(2-3):123-30. PubMed ID: 19782679
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Roscovitine binds to novel L-channel (CaV1.2) sites that separately affect activation and inactivation.
    Yarotskyy V; Gao G; Du L; Ganapathi SB; Peterson BZ; Elmslie KS
    J Biol Chem; 2010 Jan; 285(1):43-53. PubMed ID: 19887376
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Block of human CaV3 channels by the diuretic amiloride.
    Lopez-Charcas O; Rivera M; Gomora JC
    Mol Pharmacol; 2012 Oct; 82(4):658-67. PubMed ID: 22767612
    [TBL] [Abstract][Full Text] [Related]  

  • 13. State-dependent verapamil block of the cloned human Ca(v)3.1 T-type Ca(2+) channel.
    Freeze BS; McNulty MM; Hanck DA
    Mol Pharmacol; 2006 Aug; 70(2):718-26. PubMed ID: 16699084
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effect of mibefradil on voltage-dependent gating and kinetics of T-type Ca(2+) channels in cortisol-secreting cells.
    Gomora JC; Xu L; Enyeart JA; Enyeart JJ
    J Pharmacol Exp Ther; 2000 Jan; 292(1):96-103. PubMed ID: 10604935
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Roscovitine: a novel regulator of P/Q-type calcium channels and transmitter release in central neurons.
    Yan Z; Chi P; Bibb JA; Ryan TA; Greengard P
    J Physiol; 2002 May; 540(Pt 3):761-70. PubMed ID: 11986366
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The separation of antagonist from agonist effects of trisubstituted purines on CaV2.2 (N-type) channels.
    Buraei Z; Elmslie KS
    J Neurochem; 2008 May; 105(4):1450-61. PubMed ID: 18221369
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Inactivation properties of human recombinant class E calcium channels.
    Jouvenceau A; Giovannini F; Bath CP; Trotman E; Sher E
    J Neurophysiol; 2000 Feb; 83(2):671-84. PubMed ID: 10669483
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Voltage-dependent calcium channels.
    Lacinová L
    Gen Physiol Biophys; 2005 Jun; 24 Suppl 1():1-78. PubMed ID: 16096350
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Regulation of Kv4.3 voltage-dependent gating kinetics by KChIP2 isoforms.
    Patel SP; Parai R; Parai R; Campbell DL
    J Physiol; 2004 May; 557(Pt 1):19-41. PubMed ID: 14724186
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Monovalent currents through the T-type Cav3.1 channels and their block by Mg2+.
    Kurejová M; Pavlovicová M; Lacinová L
    Gen Physiol Biophys; 2007 Sep; 26(3):234-9. PubMed ID: 18063852
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.